AlzeCure Pharma AB (publ) (STO:ALZCUR)

Market Cap	1.09B +167.6%
Revenue (ttm)	97.33M
Net Income	30.72M
EPS	0.27
Shares Out	137.90M
PE Ratio	29.42
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	995,705
Open	7.94
Previous Close	7.94
Day's Range	7.70 - 8.30
52-Week Range	1.30 - 8.26
Beta	-0.07
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About AlzeCure Pharma AB

AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857 and ACD680 that...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 10
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ALZCUR

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 2, 2026

Data Sources Report a data error